Fidelity Disruptive Medicine ETF
FMED
7 hedge funds and large institutions have $37M invested in Fidelity Disruptive Medicine ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
7% more capital invested
Capital invested by funds: $34.6M → $37M (+$2.42M)
0.96% more ownership
Funds ownership: 65.63% → 66.59% (+0.96%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$632K |
| 2 |
GJIA
Glass Jacobson Investment Advisors
Owings Mills,
Maryland
|
+$21.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$130K |
| 2 |
PSFG
Park Square Financial Group
Roswell,
Georgia
|
-$14.1K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $18.3M | -$1.04K | -43 | -0% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $17.5M | -$130K | -5,388 | -0.8% |
|
|
3
Jane Street
New York
| $1.17M | +$632K | +26,157 | +127% |
|
|
GJIA
4
Glass Jacobson Investment Advisors
Owings Mills,
Maryland
| $21.8K | +$21.1K | +875 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $19K | +$4.28K | +177 | +30% |
|
|
CPBTD
6
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.42K | – | – | – |
|
|
GEA
7
Glen Eagle Advisors
Kingston,
New Jersey
| $2.25K | – | – | – |
|
|
PSFG
8
Park Square Financial Group
Roswell,
Georgia
| – | -$14.1K | -589 | Closed |
|
FMED Hedge Fund Activity: Q3 2025 in Review
7 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q3 2025, worth a combined $37M — up 7% from $34.6M a quarter earlier.
Fund positioning in FMED was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $632K. The largest seller was Wealth Enhancement Advisory Services, cutting an estimated $130K.
- 7 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $37M of Fidelity Disruptive Medicine ETF stock for Q3 2025, up 7% quarter-over-quarter.
- 1 fund opened new Fidelity Disruptive Medicine ETF positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest Fidelity Disruptive Medicine ETF buyer in Q3 2025 was Jane Street, an estimated $632K added.
- The largest Fidelity Disruptive Medicine ETF seller in Q3 2025 was Wealth Enhancement Advisory Services, an estimated $130K sold.
Based on aggregated 13F filings for Q3 2025.